Andres Felipe Deik, MD, MSEd, FAAN
Associate Professor of Clinical Neurology
Director, Comprehensive Parkinsonism Evaluation (COPE) Clinic, Parkinson's Disease and Movement Disorders Center, University of Pennsylvania
Director, Experimental therapeutics, Parkinson's Disease and Movement Disorders Center, University of Pennsylvania
Co-director, Neurology residency movement rotation, Parkinson's Disease and Movement Disorders Center, University of Pennsylvania
Director, Neuroradiology Conference at Pennsylvania Hospital, Parkinson's Disease and Movement Disorders Center, University of Pennsylvania
Director, Movement Disorders Video Rounds, Parkinson's Disease and Movement Disorders Center, University of Pennsylvania
Program Director, Movement Disorder Fellowship , Parkinson's Disease and Movement Disorders Center, University of Pennsylvania
Department: Neurology
Contact information
Parkinson’s Disease and Movement Disorders Center
University of Pennsylvania
330 South 9th Street
2nd Floor
Philadelphia, PA 19107
University of Pennsylvania
330 South 9th Street
2nd Floor
Philadelphia, PA 19107
Office: 215-829-7049
Fax: 215-829-6606
Fax: 215-829-6606
Publications
Education:
M.D. (Medicine)
Universidad del Norte, Barranquilla, Colombia, 2005.
M.S.Ed. (Master in Medical Education)
University of Pennsylvania, 2016.
Permanent linkM.D. (Medicine)
Universidad del Norte, Barranquilla, Colombia, 2005.
M.S.Ed. (Master in Medical Education)
University of Pennsylvania, 2016.
Description of Clinical Expertise
Movement Disorders Specialist with interest in dystonia. Expert in the administration of botulinum toxin injections and deep brain stimulation programming.Description of Other Expertise
Master in Medical Education. Associate Program Director of the Movement Disorders Fellowship at the University of Pennsylvania's Parkinson's Disease and Movement Disorders Center.Description of Research Expertise
Clinical trialist in Movement Disorders.Selected Publications
Beylergil SB, Mukunda KN, Elkasaby M, Perlmutter JS, Factor S, Bäumer T, Feurestein J, Shelton E, Bellows S, Jankovic J, Mahajan A, Wamer-Rosen T, Reich SG, Wagle Shukla A, Malady I, Espay A, Duque K, LeDoux MS, Saunders-Pullman R, Leaver K, Frank S, Pantelyat A, Fung V, Pirio Richardson S, Berman B, Stover N, Deik A, Ondo W, Groth C, Jinnah HA and Shaikh AG.: Tremor in cervical dystonia. Dystonia Mar 2024 Notes: doi: 10.3389/dyst.2024.11309.Baldwin A, Copeland J, Azage M, Dratch L, Johnson K, Paul RA, Amado DA, Baer M, Deik A, Elman LB, Guo M, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn CC, Tropea TF, Scherer SS, Shinohara RT, Hamilton RH, Ellis CA. : Disparities in Genetic Testing for Neurologic Disorders. Neurology 102(6), Mar 2024 Notes: doi: 10.1212/WNL.0000000000209161. Epub 2024 Mar 6.
Arezoumandan S, Cousins KAQ, Ohm DT, Lowe M, Chen M, Gee J, Phillips JS, McMillan CT, Luk KC, Deik A, Spindler MA, Tropea TF, Weintraub D, Wolk DA, Grossman M, Lee V, Chen-Plotkin AS, Lee EB, Irwin DJ.: Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease. Ann Clin Transl Neurol Jan 2024 Notes: doi: 10.1002/acn3.51988.
Younce JR, Cascella RH, Berman BD, Jinnah HA, Bellows ST, Feuerstein J, Shukla AW, Mahajan A, Chang F, Duque KR, Reich S, Richardson SP, Deik A, Stover N, Luna JM, Norris SA: Anatomical categorization of isolated non-focal dystonia: novel and existing patterns using a data-driven approach Dystonia Jun 2023 Notes: DOI: 10.3389/dyst.2023.11305.
Deik A: Potential Benefits and Perils of Incorporating ChatGPT to the Movement Disorders Clinic. J Mov Disord 16(2): 158-162, May 2023 Notes: https://doi.org/10.14802/jmd.23072.
Cousins KA, Irwin DJ, Chen-Plotkin A, Shaw LM, Arezoumandan S, Lee EB, Wolk DA, Weintraub D, Spindler M, Deik A, Grossman M, Tropea TF: Plasma GFAP associates with secondary Alzheimer’s pathology in Lewy body disease. Annals of Clinical and Translational Neurology 10(5): 802-813, Mar 2023.
Shellikeri S, Cho S, Cousins KAQ, Liberman M, Howard E, Balganorth Y, Weintraub D, Spindler M, Deik A, Lee EB, Trojanowski JQ, Irwin D, Wolk D, Grossman M, Nevler N.: Natural speech markers of Alzheimer's disease co-pathology in Lewy body dementias. Parkinsonism Relat Disord 6(102): 94-100, Aug 2022 Notes: doi: 10.1016/j.parkreldis.2022.07.023. Online ahead of print.
Cho S, Agmon G, Shellikeri S, Cousins KAQ, Ash S, Irwin DJ, Spindler M, Deik AF, Elman LB, Quinn C, Liberman M, Grossman M, Nevler N: Prosodic characteristics of prepausal words produced by patients with neurodegenerative disease. Speech Prosody Page: 120-124, May 2022 Notes: doi: 10.21437/speechprosody.2022-25.
Ohm DT, Cousins KAQ, Xie SX, Peterson C, McMillan CT, Massimo L, Raskovsky K, Wolk DA, Van Deerlin VM, Elman L, Spindler M, Deik A, Trojanowski JQ, Lee EB, Grossman M, Irwin DJ. : Signature laminar distributions of pathology in frontotemporal lobar degeneration. Acta Neuropathol Jan 2022 Notes: doi: 10.1007/s00401-021-02402-3.
Parkinson Study Group SURE-PD3 Investigators, Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, Scott B, Gauger L, Aldred J, Bixby M, Ciccarello J, Gunzler SA, Henchcliffe C, Brodsky M, Keith K, Hauser RA, Goetz C, LeDoux MS, Hinson V, Kumar R, Espay AJ, Jimenez-Shahed J, Hunter C, Christine C, Daley A, Leehey M, de Marcaida JA, Friedman JH, Hung A, Bwala G, Litvan I, Simon DK, Simuni T, Poon C, Schiess MC, Chou K, Park A, Bhatti D, Peterson C, Criswell SR, Rosenthal L, Durphy J, Shill HA, Mehta SH, Ahmed A, Deik AF, Fang JY, Stover N, Zhang L, Dewey RB Jr, Gerald A, Boyd JT, Houston E, Suski V, Mosovsky S, Cloud L, Shah BB, Saint-Hilaire M, James R, Zauber SE, Reich S, Shprecher D, Pahwa R, Langhammer A, LaFaver K, LeWitt PA, Kaminski P, Goudreau J, Russell D, Houghton DJ, Laroche A, Thomas K, McGraw M, Mari Z, Serrano C, Blindauer K, Rabin M, Kurlan R, Morgan JC, Soileau M, Ainslie M, Bodis-Wollner I, Schneider RB, Waters C, Ratel AS, Beck CA, Bolger P, Callahan KF, Crotty GF, Klements D, Kostrzebski M, McMahon GM, Pothier L, Waikar SS, Lang A, Mestre T.: Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial. JAMA 326(10): 926-939, Sep 2021 Notes: doi: 10.1001/jama.2021.10207.